tiprankstipranks
Vicore Pharma Holding AB (DE:6Y4)
FRANKFURT:6Y4
Germany Market
6Y4
Vicore Pharma Holding AB
RESEARCH TOOLSreports

Vicore Pharma Holding AB (6Y4) Cash flow

2 Followers

Vicore Pharma Holding AB Cash Flow

DE:6Y4's free cash flow for Q4 2025 was kr0.00. For the 2025 fiscal year, DE:6Y4's free cash flow was decreased by kr164.95M and operating cash flow was kr-81.48M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
kr -374.44Mkr -164.95Mkr -249.58Mkr -299.92Mkr -265.17M
Investing Cash Flow
kr -601.81Mkr 149.04Mkr -144.46Mkr 74.00Mkr -7.00M
Financing Cash Flow
kr 430.54Mkr 834.06Mkr 470.86Mkr 187.04Mkr 318.18M
End Cash Position
kr 578.15Mkr 1.16Bkr 333.62Mkr 256.80Mkr 294.20M
Free Cash Flow
kr 0.00kr -164.95Mkr -448.62Mkr -302.92Mkr -265.17M
Currency in SEK

Vicore Pharma Holding AB Cash Flow